Taking Wegovy a Day Late: What the Guidance Actually Says

Wegovy (semaglutide) has a half-life of approximately one week, which is why a one-day delay rarely changes how the medicine is working in your body.
The official guidance allows a missed injection to be given up to five days late; beyond that, skip the dose and keep to the original weekly schedule.
Your injection day resets to whatever day you took the late dose — so if you moved from Monday to Tuesday, Tuesday becomes your new day going forward.
Adjusting timing is fine in principle, but the decision to change your schedule or dosing pattern in any ongoing way belongs with your prescriber, not a general rule.

If you've missed your usual injection day and are wondering whether taking Wegovy a day late matters, the short answer is: it's manageable. The Wegovy Patient Information Leaflet and the NHS semaglutide medicines page confirm that a missed dose can be taken up to five days after it was due — after that, skip it and return to your usual day. Semaglutide has a long half-life by design, so a 24-hour delay won't wipe out a week's coverage. What you do next depends on how late you actually are, and this page works through that clearly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The Evidence Behind Wegovy's Flexible Dosing Window and What It Means in Practice

Why semaglutide's half-life makes a one-day delay less alarming than it sounds

Semaglutide was developed as a once-weekly medicine specifically because its half-life sits at roughly seven days. That pharmacokinetic profile is not a coincidence, it means plasma levels don't plunge overnight the way a short-acting medicine would. The STEP 1 trial, published in the New England Journal of Medicine, demonstrated sustained weight reduction over 68 weeks at the 2.4 mg maintenance dose, partly because consistent weekly coverage is baked into how the molecule was designed.

In plain terms: if Monday was your day and you've woken up Tuesday realising you forgot, your semaglutide levels haven't collapsed. There's still meaningful medicine in your system, and taking semaglutide a day late keeps things on track rather than undoing the week's treatment. This isn't a workaround, it's the biology the prescribing guidance is built around.

A common misconception worth setting aside gently is that missing even one day of a weekly injection means the whole week's treatment is lost. It doesn't. If you want to read more about how semaglutide works as a medicine, including why its extended half-life is so central to the way it's prescribed, that page covers the detail. You're not starting from zero.

The five-day rule: exactly how the window works when you're taking Wegovy late

The Wegovy Patient Information Leaflet, reflected in NHS guidance on semaglutide, gives a clear instruction for a missed dose. If your usual injection day has passed:

Take the missed dose as soon as you remember, provided there are at least five days until your next scheduled injection. If the gap between the late dose and the next due date is fewer than five days, skip the missed dose entirely. Do not double up to compensate. Return to your normal weekly schedule from the next due date.

A practical example: your usual day is Sunday. You remember on Wednesday, four days later. Wednesday is within five days of the following Sunday (three days away), so you'd skip this one and pick up on Sunday as planned. If you'd remembered on Tuesday instead, with five days to the next Sunday, you could take it then and shift your day to Tuesday going forward. Guidance on what to do when Wegovy is one day late walks through these scenarios in more detail if Tuesday's situation is exactly where you find yourself.

Details on how timing choices interact with the titration schedule are worth discussing with your prescriber. If you're new to Wegovy and still working through the starter doses, or if delays have been recurring, that conversation matters more than a single missed day.

What changes (and what doesn't) when you shift your injection day

Taking your dose late by a day or two quietly moves your injection schedule. The day you give the late dose becomes your new weekly anchor. This is intentional in the guidance and not a problem provided it's consistent afterwards. Where it can become complicated is if each week the day drifts further, or if you find yourself wondering whether you can take Wegovy a day later the following week to correct the shift. Repeated small adjustments can cause uneven intervals that irritate the GI system more than steady weekly dosing would.

Side effects from semaglutide are mostly gastrointestinal (nausea, changes in appetite, occasionally loose stools or constipation) and they tend to track dose changes and inconsistent intervals rather than stable weekly use. Keeping the interval as close to seven days as possible, even after a late dose, is the straightforward way to avoid adding unnecessary turbulence. The NHS medicines page for semaglutide lists the full side-effect profile if you want to read it alongside your own experience.

If you're monitoring how Wegovy fits your situation more broadly (including cost, eligibility, and how private prescribing works) the weight-loss treatment overview is a useful starting point.

When to speak to your prescriber rather than adjust alone

Most single delayed doses don't need a clinical call. But there are situations where speaking to a prescriber is the right move: if doses have been missed repeatedly, if you're unsure whether you injected or not, if you're experiencing side effects that are getting worse rather than settling, or if you're managing other medicines alongside Wegovy that might interact with irregular dosing. The same principles apply if you have ever considered taking Wegovy a day early, which carries its own timing considerations that are worth reviewing before making that call.

For patients already prescribed through a regulated service, aftercare contact is part of the picture. At nume, prescribers are available seven days a week for clinical questions, that includes the kind of timing query that doesn't warrant an A&E trip but also shouldn't be answered by a forum post. If you haven't yet started treatment and want a clinical review, checking your eligibility takes a few minutes and costs nothing.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions